Targeting Sirtuin 1 for therapeutic potential: Drug repurposing approach integrating docking and molecular dynamics simulations

被引:3
|
作者
Alrouji, Mohammed [1 ]
Alhumaydhi, Fahad A. [2 ]
Alsayari, Abdulrhman [3 ,4 ]
Sharaf, Sharaf E. [5 ]
Shafi, Sheeba [6 ]
Anwar, Saleha [7 ]
Shahwan, Moyad [8 ]
Atiya, Akhtar [3 ]
Shamsi, Anas [8 ]
机构
[1] Shaqra Univ, Coll Appl Med Sci, Dept Med Labs, Shaqra, Saudi Arabia
[2] Qassim Univ, Coll Appl Med Sci, Dept Med Labs, Buraydah, Saudi Arabia
[3] King Khalid Univ KKU, Coll Pharm, Dept Pharmacognosy, Abha, Saudi Arabia
[4] King Khalid Univ KKU, Complementary & Alternat Med Unit, Abha, Saudi Arabia
[5] Qura Univ Makkah, Coll Pharm Umm Al, Pharmaceut Chem Dept, Mecca, Saudi Arabia
[6] King Faisal Univ, Coll Appl Med Sci, Dept Nursing, Al Hasa, Saudi Arabia
[7] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India
[8] Ajman Univ, Ctr Med & Bioallied Hlth Sci, Ajman, U Arab Emirates
来源
PLOS ONE | 2023年 / 18卷 / 12期
关键词
INHIBITOR; DISCOVERY; MECHANISM;
D O I
10.1371/journal.pone.0293185
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Identifying novel therapeutic agents is a fundamental challenge in contemporary drug development, especially in the context of complex diseases like cancer, neurodegenerative disorders, and metabolic syndromes. Here, we present a comprehensive computational study to identify potential inhibitors of SIRT1 (Sirtuin 1), a critical protein involved in various cellular processes and disease pathways. Leveraging the concept of drug repurposing, we employed a multifaceted approach that integrates molecular docking and molecular dynamics (MD) simulations to predict the binding affinities and dynamic behavior of a diverse set of FDA-approved drugs from DrugBank against the SIRT1. Initially, compounds were shortlisted based on their binding affinities and interaction analyses to identify safe and promising binding partners for SIRT1. Among these candidates, Doxercalciferol and Timiperone emerged as potential candidates, displaying notable affinity, efficiency, and specificity towards the binding pocket of SIRT1. Extensive evaluation revealed that these identified compounds boast a range of favorable biological properties and prefer binding to the active site of SIRT1. To delve deeper into the interactions, all-atom MD simulations were conducted for 500 nanoseconds (ns). These simulations assessed the conformational dynamics, stability, and interaction mechanism of the SIRT1-Doxercalciferol and SIRT1-Timiperone complexes. The MD simulations illustrated that the SIRT1-Doxercalciferol and SIRT1-Timiperone complexes maintain stability over a 500 ns trajectory. These insightful outcomes propose that Doxercalciferol and Timiperone hold promise as viable scaffolds for developing potential SIRT1 inhibitors, with implications for tackling complex diseases such as cancer, neurodegenerative disorders, and metabolic syndromes.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Exploring New Potential Pkcθ Inhibitors Using Pharmacophore Modeling, Molecular Docking Analysis, and Molecular Dynamics Simulations
    Yao, Yao
    Pang, Wen-Wei
    Hu, An-Zheng
    Chen, Hai-Yan
    Qi, Zhong-Quan
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024,
  • [22] In Silico Repurposing of a Novel Inhibitor (drug) of EGFR and VEGFR-2 Kinases of Cancer by Pharmacokinetics, Toxicity, Molecular Docking, and Molecular Dynamics Simulation
    Ibraheim, Mona H.
    Maher, Ibrahim
    Khater, Ibrahim
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2024, 196 (11) : 8332 - 8365
  • [23] Insight into the binding mode of a novel LSD1 inhibitor by molecular docking and molecular dynamics simulations
    Zhang, Xu
    Li, Mo
    Wang, Yu
    Zhao, Yi
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2015, 35 (05) : 363 - 369
  • [24] Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models
    Fadlalla, Mohamed
    Ahmed, Mazin
    Ali, Musab
    Elshiekh, Abdulrhman A.
    Yousef, Bashir A.
    CURRENT PHARMACOLOGY REPORTS, 2022, 8 (03) : 212 - 226
  • [25] Computational evaluation on molecular stability, reactivity, and drug potential of frovatriptan from DFT and molecular docking approach
    Chaudhary, Manoj Kumar
    Srivastava, Anubha
    Singh, Keshav Kumar
    Tandon, Poonam
    Joshi, Bhawani Datt
    COMPUTATIONAL AND THEORETICAL CHEMISTRY, 2020, 1191
  • [26] Combining QSAR techniques, molecular docking, and molecular dynamics simulations to explore anti-tumor inhibitors targeting Focal Adhesion Kinase
    Liu, Yuan
    Tong, Jian-Bo
    Gao, Peng
    Fan, Xuan-lu
    Xiao, Xue-chun
    Xing, Yi-chaung
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025, 43 (07) : 3749 - 3765
  • [27] Dual targeting inhibitors for HIV-1 capsid and cyclophilin A: molecular docking, molecular dynamics, and quantum mechanics
    Obubeid, Fauad O.
    Eltigani, Maha M.
    Mukhtar, Rua M.
    Ibrahim, Reham A.
    Alzain, Muna A.
    Elbadawi, Fatima A.
    Ghaboosh, Hiba
    Alzain, Abdulrahim A.
    MOLECULAR SIMULATION, 2022, 48 (16) : 1476 - 1489
  • [28] OSI-027 as a Potential Drug Candidate Targeting Upregulated Hub Protein TAF1 in Potential Mechanism of Sinonasal Squamous Cell Carcinoma: Insights from Proteomics and Molecular Docking
    Panthong, Watcharapong
    Pientong, Chamsai
    Nukpook, Thawaree
    Heawchaiyaphum, Chukkris
    Aromseree, Sirinart
    Ekalaksananan, Tipaya
    BIOLOGY-BASEL, 2024, 13 (12):
  • [29] Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies
    Majeed, Arshia
    Hussain, Waqar
    Yasmin, Farkhanda
    Akhtar, Ammara
    Rasool, Nouman
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [30] In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations
    Rezvani, Saba
    Ebadi, Ahmad
    Razzaghi-Asl, Nima
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (21) : 10665 - 10676